No abstract available
MeSH terms
-
Brentuximab Vedotin
-
Hodgkin Disease / drug therapy*
-
Humans
-
Immunoconjugates / therapeutic use*
-
Ki-1 Antigen / immunology
-
Lymphoma, Non-Hodgkin / drug therapy*
-
Lymphoma, Non-Hodgkin / immunology
-
Molecular Targeted Therapy
-
Recurrence
Substances
-
Immunoconjugates
-
Ki-1 Antigen
-
Brentuximab Vedotin